Severe haemophilia usually becomes apparent in the first years of
life - often when the child starts to move about independently.
Haemorrhages often occur in the joints, particularly the weight
bearing joints such as knees and ankles.
This pain is often unbearable, and helping young children and adults
living with haemophilia to avoid this drives the passion in our research.
We combine our experience in protein design with collaborations in
the global scientific community to discover and develop effective and
safe medicines for people with haemophilia and other rare bleeding disorders.
In the video above, meet Ulla Hedner, a leading pioneer in
haemophilia treatment. Ulla explains her passion and dedication to
help haemophilia patients.